No data to
display.
Cytodyn Inc. revenue decreases to $0 in 2023 from previous year
By NewsInMinutes on Sep 15, 2023 | 04:35 AM IST
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| May 2023 | $0 | $79.82 million | loss |
| May 2022 | $266,000 | $210.82 million | loss |
Cytodyn Inc. [CYDY] has reported $79.82 million loss for the fiscal year ending May 31, 2023.
Revenue for the year was $0 with operating income of $40.58 million.
The Vancouver, Washington (WA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $109.50 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.